Stephen P. Mawer Sells 3,655 Shares of Calumet Specialty Products Partners, L.P. (NASDAQ:CLMT) Stock

Calumet Specialty Products Partners, L.P. (NASDAQ:CLMT) Director Stephen P. Mawer sold 3,655 shares of the firm’s stock in a transaction dated Monday, March 24th. The shares were sold at an average price of $12.88, for a total value of $47,076.40. Following the completion of the transaction, the director now owns 287,307 shares in the company, valued at approximately $3,700,514.16. This represents a 1.26 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.

Calumet Specialty Products Partners Stock Performance

Shares of NASDAQ CLMT opened at $13.45 on Friday. Calumet Specialty Products Partners, L.P. has a 52-week low of $9.97 and a 52-week high of $25.29. The stock has a market cap of $1.16 billion, a P/E ratio of -4.87 and a beta of 1.88. The firm has a 50 day moving average price of $14.82 and a 200 day moving average price of $18.47.

Calumet Specialty Products Partners (NASDAQ:CLMT) last announced its quarterly earnings results on Friday, February 28th. The oil and gas company reported ($0.47) earnings per share for the quarter, topping analysts’ consensus estimates of ($1.06) by $0.59. The firm had revenue of $949.50 million for the quarter, compared to the consensus estimate of $921.76 million. During the same period in the prior year, the business earned ($0.59) earnings per share. The company’s revenue for the quarter was down 2.8% compared to the same quarter last year. Analysts predict that Calumet Specialty Products Partners, L.P. will post -3.02 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several brokerages have recently issued reports on CLMT. UBS Group raised shares of Calumet Specialty Products Partners from a “sell” rating to a “neutral” rating and reduced their target price for the company from $15.00 to $12.00 in a research note on Monday, March 17th. TD Cowen cut shares of Calumet Specialty Products Partners from a “buy” rating to a “hold” rating and reduced their price objective for the company from $26.00 to $16.00 in a research note on Tuesday, March 4th. HC Wainwright reiterated a “buy” rating and set a $33.00 target price on shares of Calumet Specialty Products Partners in a research report on Monday, March 3rd. Finally, Wells Fargo & Company reduced their price target on Calumet Specialty Products Partners from $29.00 to $28.00 and set an “overweight” rating on the stock in a research report on Wednesday, March 5th. One equities research analyst has rated the stock with a sell rating, two have given a hold rating and three have given a buy rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Hold” and an average target price of $20.80.

About Calumet Specialty Products Partners

Calumet, Inc engages in the manufacturing, formulating, and marketing of a diversified slate of specialty branded products and renewable fuels to customers across a broad range of consumer-facing and industrial markets. It operates through the following segments: Specialty Products & Solutions, Performance Brands, Montana/Renewables, and Corporate.